The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

Corporation announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM Evidence. The AHFIRM trial was ...

SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC) (the 'Company') today announced that it has engaged a Clinical Research Organization (CRO) to conduct a ...

Brii said it agreed to purchase the assets from VBI Vaccines Inc. and its creditors for $18 million. The deal gives Brii full access to the remaining IP, patents and materials related to BRII-179, an ...

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Bluejay Therapeutics’ fully human ...

The initial diagnosis of chronic HBV infection can be made by the use of serological markers. The presence of HBsAg generally indicates chronic infection, while antibodies directed against HBsAg ...

Hepatitis B is inflammation of the liver in hominoidea, including humans, caused by the hepatitis B virus. The virus is transmitted by parenteral exposure, such as by exposure to infectious blood ...

The phase 3 program missed both primary and key secondary endpoints, with no statistically significant effects on relevant measures observed for patients receiving investigational treatment ...

The cease-fire deal reached Wednesday between Israel and Hamas is the first step in a process that could see the release of all hostages from the Gaza Strip and the withdrawal of the Israeli military.

You can contract hepatitis C by blood-to-blood contact. Ways to avoid reinfection to the hepatitis C virus include avoiding sharing needles and using condoms or another barrier method during sex.

What our study showed was that during a chronic hepatitis C infection, antibodies on the virus surface form an antibody cluster that persistently stimulates the B cells to mutate," explains lead ...